跳至主要内容
临床试验/NCT04093427
NCT04093427终止不适用

Einfluss Einer Inversen Druckrampe Bei Der Langzeit-Therapie Mit Nicht-invasiver Ventilation Auf Dyspnoe am Morgen Nach Therapie-Ende. Influence of an Inverse Pressure Ramp in the Long-term Therapy Mit Non-invasive Ventilation on Dyspnea in the Morning After Therapy.

Wissenschaftliches Institut Bethanien e.V2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2019年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
8
试验地点
2
主要终点
Change of dyspnea level from baseline to 12 weeks

研究概览

简要总结

Patients being treated with non-invasive home mechanical ventilation (NIV) may experience morning dyspnea after each night of NIV use, when the therapy is abruptly ended. This study aims to show that dyspnea intensity can be significantly reduced by a gentle NIV therapy end, delivered by a continuously decreasing pressure level (inverse pressure ramp) after therapy end in the morning, a feature called softSTOPP, which can configured in prismaVENT NIV devices. This could also improve therapy adherence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Diagnosis of a chronic obstructive pulmonary disease (COPD) with chronic hypercapnic insufficiency
  • Therapy with prismaVENT 30, firmware V 3.3 or higher, mode S/T, stable device settings at the time of inclusion without need to adapt ventilation parameters
  • May have co-existing obstructive sleep apnea syndrome
  • Subjective dyspnea ≥3 (Borg scale) after end of ventilation therapy in the morning
  • Written informed consent for study participation including data protection

排除标准

  • Missing written informed consent for study participation including data protection
  • Contraindication for positive airway pressure therapy
  • Use of the softSTOPP feature before study inclusion
  • Participation in another study, which influences NIV therapy by defining device settings or titration
  • Concomitant oxygen therapy

结局指标

主要结局

Change of dyspnea level from baseline to 12 weeks

时间窗: 12 weeks

Delta value of morning dyspnea from baseline to 12 weeks as measured by the Borg Scale. The Borg Scale ranges from 0 (no perceived dyspnea at all) to 10 (maximum perceived dyspnea).

次要结局

未报告次要终点

研究者

发起方
Wissenschaftliches Institut Bethanien e.V
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验